[1]罗智浩,李高俊,韩旻君,等.增液承气汤对脓毒症肠功能障碍大鼠炎症反应、免疫及肠功能的影响[J].陕西中医,2024,(12):1614-1618.[doi:DOI:10.3969/j.issn.1000-7369.2024.12.006]
　LUO Zhihao,LI Gaojun,HAN Minjun,et al.Effect of Zengye Chengqi decoction on inflammation,immunity and intestinal function in rats with septic intestinal dysfunction[J].,2024,(12):1614-1618.[doi:DOI:10.3969/j.issn.1000-7369.2024.12.006]
点击复制

增液承气汤对脓毒症肠功能障碍大鼠炎症反应、免疫及肠功能的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年12期
页码:
1614-1618
栏目:
基础研究
出版日期:
2024-12-05

文章信息/Info

Title:
Effect of Zengye Chengqi decoction on inflammation,immunity and intestinal function in rats with septic intestinal dysfunction
作者:
罗智浩; 李高俊; 韩旻君; 林泽辉
(广东省中医院海南医院 海南省中医院急救中心,海南 海口 570203)
Author(s):
LUO Zhihao; LI Gaojun; HAN Minjun; LIN Zehui
(Guangdong Hospital of Traditional Chinese Medicine Hainan Hospital,Emergency Center of Hainan Hospital of Traditional Chinese Medicine,Haikou 570203,China)
关键词:
脓毒症;  肠功能障碍;  增液承气汤;  炎症反应;  免疫;  分泌型免疫球蛋白
Keywords:
Sepsis;  Intestinal dysfunction;  Zengye Chengqi decoction;  Inflammation reaction;  Immunity;  SIgA
分类号:
R 278
DOI:
DOI:10.3969/j.issn.1000-7369.2024.12.006
文献标志码:
A
摘要:
目的:研究增液承气汤对脓毒症肠功能障碍大鼠炎症反应、免疫及肠功能的影响。方法:将大鼠随机分为五组,每组20只,除假手术组外,其余各组建立脓毒症模型。各组分别进行对应药物干预后,ELISA检测白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、分泌型免疫球蛋白(SIgA)水平。HE染色观察大鼠肠道病理改变。流式细胞术检测大鼠胸腺、脾脏及外周血淋巴细胞凋亡情况。结果:CLP模型组IL-6、TNF-α水平较假手术组明显升高,增液承气汤各剂量组IL-6、TNF-α水平较CLP模型组明显下降,以增液承气汤高剂量组下降更显著(均P<0.05)。CLP模型组SigA水平较假手术组下降,差异有统计学意义(P<0.05); 增液承气汤低、中剂量组SigA水平比较差异无统计学意义(P>0.05); 增液承气汤高剂量组血清SIgA水平高于CLP模型组(P<0.05)。CLP模型组可见肠上皮变性、脱落,黏膜下层坏死; 增液承气汤中、高剂量组可见肠上皮变性,绒毛较完整,炎性细胞比CLP组少。与CLP模型组比较,增液承气汤中、高剂量组Chiu's评分下降(均P<0.05)。与假手术组对比,CLP模型组胸腺、脾脏淋巴细胞凋亡水平明显上升(均P<0.05); 与CLP组对比,增液承气汤各剂量组外周血、胸腺、脾脏淋巴细胞凋亡水平下降(均P<0.05)。结论:增液承气汤可改善CLP大鼠肠道损伤,减轻炎症反应,提高SIgA水平,抑制淋巴细胞凋亡。
Abstract:
Objective:To study the effects of Zengye Chengqi decoction on inflammation,immunity and intestinal function in rats with septic intestinal dysfunction.Methods:The rats were randomly divided into 5 groups,with 20 rats in each group.Sepsis model was established in all groups except the sham operation group.The levels of interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)and secreted immunoglobulin(SIgA)in each group were detected by ELISA after corresponding drug intervention.The pathological changes of intestinal tract were observed by HE staining.The apoptosis of thymus,spleen and peripheral blood lymphocytes was detected by flow cytometry.Results:The levels of IL-6 and TNF-α in CLP model group were significantly higher than those in sham operation group,and the levels in Zengye Chengqi decoction groups were significantly lower than those in CLP model group,especially in Zengye Chengqi decoction high-dose group(all P<0.05).The SigA level in CLP model group was lower than that in sham operation group,the difference was statistically significant(P<0.05).There was no significant difference in SigA level between Zengye Chengqi decoction low dose and medium dose groups(P>0.05).Serum SIgA level in Zengye Chengqi decoction high dose group was higher than that in CLP model group(P<0.05).In CLP model group,intestinal epithelial degeneration,exfoliation and submucosal necrosis were observed.Epithelial degeneration,villi were more complete and inflammatory cells in Zengye Chengqi decoction group were less than CLP model group.Compared with CLP model group,the Chiu's scores in Zengye Chengqi decoction medium and high dose groups were decreased(P<0.05).Compared with sham operation group,the apoptosis level of thymus and spleen lymphocytes in CLP model group was significantly increased(all P<0.05).Compared with CLP group,the apoptosis levels of lymphocytes in peripheral blood,thymus and spleen of Zengye Chengqi decoction groups were decreased(all P<0.05).Conclusion:Zengye Chengqi decoction can improve intestinal injury,reduce inflammation reaction,increase SIgA level and inhibit lymphocyte apoptosis in CLP rats.

参考文献/References:

[1] RUDD K E,JOHNSON S C,AGESA K M,et al.Global,regional,and national sepsis incidence and mortality,1990-2017:Analysis for the global burden of disease study[J].Lancet,2020,395(10219):200-211.
[2] GAVELLI F,CASTELLO L M,AVANZI G C.Management of sepsis and septic shock in the emergency department[J].Intern Emerg Med,2021,16(6):1649-1661.
[3] 王仲,魏捷,朱华栋,等.中国脓毒症早期预防与阻断急诊专家共识[J].中国急救医学,2020,40(7):577-588.
[4] SARTINI C,LANDONI G,BELLETTI A,et al.Beyond the surviving sepsis campaign guidelines:A systematic review of interventions affecting mortality in sepsis[J].Panminerva Med,2024,66(1):55-62.
[5] KOBRITZ M,NOFI C,SFAKIANOS M,et al.Targeting sting to reduce sepsis-induced acute intestinal injury[J].Surgery,2023,174(4):1071-1077.
[6] LING H,LIN Y,BAO W,et al.Erythropoietin-mediated IL-17 F attenuates sepsis-induced gut microbiota dysbiosis and barrier dysfunction[J].Biomed Pharmacother,2023,165:115072.
[7] 杨潇,任凯,贾婷婷,等.中医药治疗脓毒症的研究进展[J].中国中医急症,2020,29(5):933-936.
[8] 王丰,李弼仁,林泽辉.西医基础疗法联合增液承气汤治疗脓毒症的疗效观察[J].中国中医急症,2024,33(1):130-132.
[9] SU J,CHEN S,XIAO J,et al.Aloe-emodin ameliorates cecal ligation and puncture-induced sepsis[J].Int J Mol Sci,2023,24(15):11972.
[10] 梁焕宝,罗嘉慧.丙泊酚对体外循环大鼠Nrf2/HO-1通路及肠屏障损伤的影响[J].中国老年学杂志,2023,43(11):2775-2780.
[11] TANG Z,ZHU Y,HU X,et al.Improving intestinal barrier function in sepsis by partially hydrolysed guar gum via the suppression of the NF-κB/MLCK pathway[J].Mol Biotechnol,2024,24:1180.
[12] 肖武强,董磊,吴先正.急性胃肠损伤分级联合D-乳酸、内毒素水平测定对脓毒症患者预后的评估价值[J].陕西医学杂志,2020,49(12):1577-1583.
[13] 许永豪,罗艳霞,陈巧.大承气汤保留灌肠对脓毒症胃肠功能障碍患者炎症反应的影响[J].中西医结合研究,2021,13(6):398-401.
[14] 田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510,封3.
[15] SHAO S,ZHOU D,FENG J,et al.Regulation of inflammation and immunity in sepsis by E3 ligases[J].Front Endocrinol,2023,14:1124334.
[16] 王自力,王晓谦,张翥,等.増液承气汤对热结肠道型气分证大鼠肠道组织结构、血清IL-1β、IL-6及TNF-α含量的影响[J].畜牧兽医学报,2016,47(4):828-835.
[17] 姜华,邓松华.增液承气汤对肠道菌群失调大鼠神经肽分泌调节影响研究[J].四川中医,2018,36(10):46-48.
[18] 陈瑶,祁正亮,王青,等.针刺结合增液承气汤对老年慢性功能性便秘患者临床症状及胃肠功能的影响[J].微循环学杂志,2024,34(2):25-30.
[19] 杜永明,张汉洪,王森.增液承气汤联合常规治疗对大肠燥热型脓毒血症患者的临床疗效[J].中成药,2022,44(4):1126-1130.
[20] 柳蔓,吕波,李兰,等.通腑理肺汤对脓毒症肠屏障损伤大鼠肠黏膜组织闭锁小带蛋白-1、闭合蛋白 mRNA及蛋白表达的影响[J].陕西中医,2024,45(1):8-12.
[21] 温剑艺,王首红,刘艳红,等.四磨汤通过调控NF-κB信号通路改善重度脓毒症大鼠结肠上皮细胞屏障功能障碍炎症状态作用研究[J].陕西中医,2023,44(10):1365-1371.
[22] OSURU H P,IKEDA K,ATLURI N,et al.Moderate exercise-induced dynamics on key sepsis-associated signaling pathways in the liver[J].Crit Care,2023,27(1):266.
[23] 赵刚,单思阳,何月月,等.血清HNL、PCT、sCD163及IL-6联合检测在老年患者脓毒症诊断中的应用价值[J].四川医学,2024,45(6):582-586.
[24] CAJANDER S,KOX M,SCICLUNA B P,et al.Profiling the dysregulated immune response in sepsis:Overcoming challenges to achieve the goal of precision medicine[J].Lancet Respir Med,2024,12(4):305-322.
[25] 陈建平,李小悦,傅明.脓毒症免疫抑制机制及免疫调理治疗新进展[J].医学综述,2021,27(13):2600-2605.

相似文献/References:

[1]李 军.大黄附子汤治疗危重脓毒症疗效及对患者胃肠功能改善研究[J].陕西中医,2019,(6):718.
　LI Jun..Research of Dahuang Fuzi prescription in the treatment of patients with severe sepsis improving symptoms signs and gastrointestinal function[J].,2019,(12):718.
[2]荆志强,魏维强,谷 俊,等.通腑宣肺汤对脓毒症急性肺损伤大鼠保护机制的研究*[J].陕西中医,2019,(8):987.
　JING Zhiqiang,WEI Weiqiang,GU Jun,et al.Study on the protective mechanism of the Tongfu Xuanfei decoction in sepsis rats with acute lung injury[J].,2019,(12):987.
[3]张育芳,张 谦△,王忆梅.中医方剂在脓毒症辅助治疗中的辨证应用*[J].陕西中医,2019,(8):1105.
　ZHANG Yufang,ZHANG Qian,WANG Yimei..Dialectical application of traditional Chinese medicine prescription in adjuvant treatment of sepsis[J].,2019,(12):1105.
[4]张吉丹,顼志兵△.健脾消胀方脐部敷贴治疗脓毒症胃肠功能障碍理论研究*[J].陕西中医,2019,(12):1745.
[5]蒋唯松,周与华△,王义辉,等.血必净注射液对EICU脓毒症患者炎症应激反应和心肌功能的影响*[J].陕西中医,2020,(4):502.
　JIANG Weisong,ZHOU Yuhua,WANG Yihui,et al.Effect of Xuebijing injection on inflammatory stress response and myocardial function in patients with sepsis of EICU[J].,2020,(12):502.
[6]林柏柏,沈梦雯,钱义明,等.从“痰饮”论治脓毒症毛细血管渗漏综合征[J].陕西中医,2021,(2):222.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.021]
　LIN Baibai,SHEN Mengwen,QIAN Yiming,et al.Treatment of sepsis capillary leakage syndrome from “phlegm and fluid”[J].,2021,(12):222.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.021]
[7]王煜辉,董晓斌.脓毒症相关五脏水气病理论探讨[J].陕西中医,2021,(3):353.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.022]
[8]龙 敏,张玉琴,岳 煜,等.黄连解毒汤联合西药治疗脓毒症心肌损伤疗效研究[J].陕西中医,2022,(3):329.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.014]
　LONG Min,ZHANG Yuqin,YUE Yu,et al.Study on clinical efficacy of Huanglian Jiedu decoction combined with western medicine on myocardial injury caused by sepsis[J].,2022,(12):329.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.014]
[9]董学广,傅晓夏,陈秀美,等.解毒通腑泻浊汤保留灌肠对脓毒症合并急性肾损伤患者微循环及血清炎性应激指标的影响[J].陕西中医,2022,(10):1388.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.015]
[10]钟敏林,周仙仕,李 俊,等.血流感染脓毒症患者687例临床特征、中医证素分布及其与预后的相关性分析[J].陕西中医,2022,(10):1392.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.016]
　ZHONG Minlin,ZHOU Xianshi,LI Jun,et al.Clinical characteristics,distribution of TCM syndrome elements and their correlation with prognosis in 687 patients with sepsis and bloodstream infection[J].,2022,(12):1392.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.016]

备注/Memo

备注/Memo:
基金项目:海南省自然科学基金青年基金资助项目(822QN475); 海南省自然科学基金资助高层次人才项目(821RC721); 国家中医药管理局张汉洪全国名老中医药专家传承工作室项目(0101641)
更新日期/Last Update: 2024-12-05